HIV causes intense polyclonal activation of B cells, resulting in increased numbers of
spontaneously antibody-secreting cells in the circulation and hypergammaglobulinemia. It is …

People living with human immunodeficiency virus (PLWH) are a vulnerable population with
a higher risk of severe coronavirus disease 2019 (COVID-19); therefore, vaccination is …

Despite a relatively low mutation rate, the large number of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections has allowed for substantial genetic …

SARS-CoV-2 lipid nanoparticle mRNA vaccines continue to be administered as the
predominant prophylactic measure to reduce COVID-19 disease pathogenesis. Quantifying …

Abstract Accessible SARS-CoV-2-specific immunoassays may inform clinical management
in people with HIV, particularly in case of persisting immunodysfunction. We prospectively …

Objectives: Accumulating evidence has confirmed the efficacy and safety of COVID-19
vaccines against SARS-CoV-2 infection. However, the effect of COVID-19 vaccination on …

To clarify the characteristics in immunogenicity and safety of inactivated SARS‐Cov‐2
vaccines among HIV‐infected individuals, a longitudinal cohort study was performed on HIV …

Introduction CoronaVac, an inactivated vaccine developed by Sinovac Life Sciences, has
been widely used for protection against Coronavirus Disease 2019 (COVID-19). This study …

Objectives To investigate whether SARS-CoV-2 messenger RNA (mRNA) vaccination has
an impact on HIV-related viro-immunological parameters. Methods People with HIV (PWH) …

Objective: The immunogenic nature of COVID-19 mRNA vaccines led to some initial concern
that these could stimulate the HIV reservoir. We analyzed changes in plasma HIV loads …